Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy President & CEO bought 4,300 shares at an average $9.57 ($41,150)
  2. 4 Open-market buy Director bought 800 shares at $9.50 ($7,600)
  3. 4 Open-market buy President & CEO bought 1,000 shares at $9.50 ($9,500)
  4. 4 Open-market buy President & CEO bought 600 shares at $9.50 ($5,700)
  5. 4 Open-market buy President & CEO bought 2,100 shares at an average $9.77 ($20,524)
  6. 4 Open-market buy Chief Financial Officer bought 500 shares at $9.80 ($4,900)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy President & CEO bought 1,875 shares at $9.59 ($17,981)
  17. 4 Open-market buy President & CEO bought 425 shares at $9.50 ($4,038)
  18. 4 Open-market buy President & CEO bought 200 shares at $9.00 ($1,800)
  19. 4 Open-market buy President & CEO bought 500 shares at $8.24 ($4,120)
  20. 4 Open-market buy Chief Financial Officer bought 500 shares at $8.06 ($4,030)

Page 16 of 19 · 364 filings